about
Histone deacetylase inhibitors potentiate photodynamic therapy in colon cancer cells marked by chromatin-mediated epigenetic regulation of CDKN1A.Potency of non-steroidal anti-inflammatory drugs in chemotherapy.Drug membrane transporters and CYP3A4 are affected by hypericin, hyperforin or aristoforin in colon adenocarcinoma cells.YM155, a small molecule inhibitor of survivin expression, sensitizes cancer cells to hypericin-mediated photodynamic therapy.Tacrine derivatives as dual topoisomerase I and II catalytic inhibitors.Resveratrol enhances the chemopreventive effect of celecoxib in chemically induced breast cancer in rats.Lichen secondary metabolites are responsible for induction of apoptosis in HT-29 and A2780 human cancer cell lines.PUFAs enhance oxidative stress and apoptosis in tumour cells exposed to hypericin-mediated PDT.Antitumor effect of the combination of manumycin A and Immodin is associated with antiplatelet activity and increased granulocyte tumor infiltration in a 4T1 breast tumor model.Peroral administration of 5-bromo-2-deoxyuridine in drinking water is not a reliable method for labeling proliferating S-phase cells in rats.Inhibition of GSK-3β reverses the pro-apoptotic effect of proadifen (SKF-525A) in HT-29 colon adenocarcinoma cells.Drug efflux transporters, MRP1 and BCRP, affect the outcome of hypericin-mediated photodynamic therapy in HT-29 adenocarcinoma cells.The role of p53 in the efficiency of photodynamic therapy with hypericin and subsequent long-term survival of colon cancer cells.Flow cytometric determination of 5-bromo-2'-deoxyuridine pharmacokinetics in blood serum after intraperitoneal administration to rats and mice.Procedure for improved cleaning of FACSAria cuvette flow cell.New spiro tria(thia)zolidine-acridines as topoisomerase inhibitors, DNA binders and cytostatic compounds.Inhibition of DNA topoisomerases I and II and growth inhibition of HL-60 cells by novel acridine-based compounds.Hypericin affects cancer side populations via competitive inhibition of BCRP.In vitro investigating of anticancer activity of new 7-MEOTA-tacrine heterodimers3,6-bis(3-alkylguanidino)acridines as DNA-intercalating antitumor agentsFluorinated 3,6,9-trisubstituted acridine derivatives as DNA interacting agents and topoisomerase inhibitors with A549 antiproliferative activityNovel Insights into the Effect of Hyperforin and Photodynamic Therapy with Hypericin on Chosen Angiogenic Factors in Colorectal Micro-Tumors Created on Chorioallantoic Membrane
P50
Q33781317-7B321C7D-34C9-4BB2-BB65-0FCB2EC7AD8FQ38282100-9F9223B2-3156-40ED-BBD3-399A9AC295B4Q38766617-81036DDF-81E9-4C34-9ADB-94BE78F06F61Q38767465-652567BF-F285-436D-8CAE-02942D249BB4Q38892447-8EE5FA05-6319-4F90-AE59-1D0528BE7799Q38953444-AD587E75-6FDA-4C7C-AC60-E3CFB5F946DCQ39405106-8CB3DB1E-0760-4158-A7CB-88E9D5ADF8D3Q39666784-5E84F55A-D107-4D50-895A-78E664648A72Q40461172-BA6DAE95-A0E0-439E-A428-2AF596F6D325Q40867948-9AA373C2-570B-4423-940F-0AE30BD99B60Q42717615-9C649D7A-6EDF-463E-978A-5EBF573B3E60Q43213836-B6B99A3C-515F-4210-9ABE-D7381FA74606Q43253736-3A8125D1-D168-4F06-931E-72D66F025E33Q44812940-1803F25F-7B95-4A26-90D1-CDC701DFE7F6Q45878989-38204236-04B9-4C11-94F6-84107D646499Q51307752-7D75A6A3-B74F-4E69-9477-6988349F3744Q51356597-BA4C7E15-11EA-425E-8077-DB97AD225196Q52318844-4FD147E9-842A-4E12-8BB7-E347874DD91EQ64085621-FC0C4676-19FC-4366-ACCF-6E5796815A80Q85203771-D49BF447-BD88-413D-A674-7ADE1352FEF7Q91077083-3A92C738-F1A4-43F8-B9C6-6B21D8C20971Q93082344-9253D89A-C42A-4484-94A5-6F703072C648
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Rastislav Jendzelovský
@en
Rastislav Jendzelovský
@nl
type
label
Rastislav Jendzelovský
@en
Rastislav Jendzelovský
@nl
prefLabel
Rastislav Jendzelovský
@en
Rastislav Jendzelovský
@nl
P31
P496
0000-0001-6338-0723